HIIFS
TWST icon

Harel Insurance Investments & Financial Services’s Twist Bioscience TWST Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,000
Closed -$1.36M – 872
2020
Q4 		$1.36M Buy
3,000
+1,200
+67% +$133K 0.03% 243
2020
Q3 		$137K Buy
+1,800
New +$112K ﹤0.01% 357

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Harel Insurance Investments & Financial Services's TWST Position: Q1 2021 in Review

Harel Insurance Investments & Financial Services sold out of Twist Bioscience (TWST) in Q1 2021, closing a stake of 3,000 shares — an estimated $1.36M sold.

Harel Insurance Investments & Financial Services first reported a position in TWST in Q3 2020 and held it in 2 quarters. The position peaked at $1.36M in Q4 2020. 240 funds tracked by Wall St. Rank hold TWST as of Q1 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Twist Bioscience position as of Q1 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 3,000 Twist Bioscience shares in Q1 2021, an estimated $1.36M.
  • Harel Insurance Investments & Financial Services first reported a position in Twist Bioscience in Q3 2020 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's Twist Bioscience position peaked at $1.36M in Q4 2020.
  • 240 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2021, filed 27 Apr 2021.